• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Provectus Biopharmaceuticals, Inc. (PVCT)

    -NYSE MKT
    0.45 Up 0.03(7.74%) 4:01PM EDT
    Add to Portfolio
    Prev Close:0.42
    Open:0.42
    Bid:0.42 x 1300
    Ask:0.43 x 20000
    1y Target Est:3.50
    Beta:2.90264
    Next Earnings Date:N/A
    Day's Range:0.41 - 0.45
    52wk Range:0.34 - 1.20
    Volume:156,388
    Avg Vol (3m):465,077
    Market Cap:92.59M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PVCT

    Comparison

    Symbol% ChgMkt Cap
    PVCTUp 7.74%92.59M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback